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Abstract Noggin (NOG) is an important regulator for the signaling of bone
morphogenetic proteins. In this study, we sequenced the complete coding sequence
of the canine NOG gene and characterized the nucleotide polymorphisms. The
sequence length varied from 717 to 729 bp, depending on the number of a 6-bp
tandem repeat unit (GGCGCG), an insertion that has not been observed in other
mammalian NOG genes investigated to date. It results in extensions of (Gly–Ala)3–5
in the putative NOG protein. To survey the distribution of these tandem repeat
polymorphisms, we analyzed 126 individuals in seven dog breeds. We identiﬁed
only three alleles: (GGCGCG)3, (GGCGCG)4, and (GGCGCG)5. Although the
allele frequencies were remarkably different among the breeds, the three alleles
were present in all seven of the breeds and did not show any deviation from Hardy–
Weinberg equilibrium.
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Introduction
Noggin (NOG) is a member of the bone morphogenetic protein (BMP) family and a
major extracellular antagonist of the BMP. NOG regulates dorsal induction and joint
formation in embryonic development by blocking BMP signaling (Smith and
Harland 1992; Zimmerman et al. 1996; Brunet et al. 1998; McMahon et al. 1998;
Canalis et al. 2003). NOG also controls bone regeneration and homeostasis in adults
(Canalis et al. 2003; Canalis 2009). The coding sequences of mammalian NOG
genes are contained in a single exon and are highly conserved among species
(Valenzuela et al. 1995). Nucleotide and amino acid sequence similarities are more
than 90% among humans, mice, and other mammals (Valenzuela et al. 1995). In
humans, several point mutations in the NOG gene have been linked to congenital
skeletal malformations, for example, proximal symphalangism or multiple synos-
toses syndrome (Gong et al. 1999; Marcelino et al. 2001; Hirshoren et al. 2008).
Therefore, the NOG gene is a potential candidate for involvement in congenital
skeletal malformations in domesticated dogs. Partial DNA sequences at this locus
have been deﬁned by the Canine Genome Project (NW_876332; Canis familiaris
chromosome 9 genomic contig). To the best of our knowledge, no nucleotide
polymorphisms have been described in the canine NOG gene. In the present study,
we ﬁrst determined the DNA sequence of the complete coding sequence of the
canine NOG gene, to scan for all the possible nucleotide polymorphisms encoded at
this locus. We subsequently surveyed the allelic distribution of the variable number
of tandem repeats (VNTRs) that were identiﬁed in the canine NOG gene.
Materials and Methods
Tissue and nail samples from non-sibling dogs were collected at veterinary hospitals
and dog-grooming shops in Japan; 127 samples were obtained from 24 long-haired
Miniature Dachshunds, 25 long-haired Chihuahuas, 23 Miniature Poodles, 19 Shih
Tzus, 13 Papillons, 12 Malteses, 10 Yorkshire Terriers, and 1 Beagle. Genomic
DNA was extracted from tissue or nails by a standard phenol–chloroform extraction
method (Sambrook et al. 1989) or using the QuickGene DNA tissue kit (Fuji Film,
Tokyo, Japan).
Ampliﬁcation and Sequencing of Canine NOG Coding Sequence
Four animals from three breeds were selected for DNA sequence determination of
the complete coding sequence for the canine NOG gene (one Beagle, two Miniature
Dachshunds, and one Chihuahua). Primers for polymerase chain reaction (PCR) and
sequencing were designed from dog genome draft sequences (chromosome 9,
NW_876332); rat (NM_012990), mouse (NM_008711), and human (NM_005450)
NOG gene sequences (Table 1). The primer sets of CanNOG-F1 and CanNOG-R1
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CanNOG-R2 produce about 700 bp. The two products overlapped with one another
in the canine NOG coding sequence.
The PCR was performed according to the manufacturer’s instructions for
PrimeStar HS DNA polymerase with GC buffer (Takara Biotechnology, Shiga,
Japan). The program included ﬁrst denaturation at 98C for 2 min; 35 cycles of
denaturation at 98C for 20 s, annealing at 55C for 5 s, and extension at 72C for
60 s; and ﬁnal extension at 72C for 3 min. The ampliﬁed products of each reaction
were cloned into the plasmid pCR-Blunt II-TOPO using the Zero Blunt TOPO PCR
Cloning kit (Invitrogen, Carlsbad, USA). At least ﬁve clones were isolated from
each individual and sequenced using the Big Dye Terminator version 3.1 Cycle
Sequencing Kit and ABI 3100 sequencer (Applied Biosystems, Foster City, USA)
with M13 universal primers and additional sequencing primers (Table 1).
Detection of the VNTR Polymorphisms in the NOG Coding Sequence
In order to survey the distribution of the VNTR alleles in dog breeds, we analyzed
126 animals from seven breeds (Table 2). The 300 bp DNA products of the canine
NOG gene, including the 6-bp tandem repeats (GGCGCG), were PCR-ampliﬁed
Table 1 Primers for canine NOG gene
Primer Sequence (50 to 30) Position on NW_876332
a
CanNOG-F1 TGGTGATGGAGCTGAAAGTG 13273923–13273942
CanNOG-R1 ACCACAGCCACATCTGTAACTTC 13274986–13275008
CanNOG-F2 ACCCGGACCCTATCTTTGAC 13274685–13274704
CanNOG-R2 TTTCTGGCTACAGAGACCTAGCT 13275418–13275440
CanNOG-S1
b GAAGTTACAGATGTGGCTGTGGT Reverse complement of R1
CanNOG-S2
b GTCAAAGATAGGGTCCGGGT Reverse complement of F2
a Canis familiaris chromosome 9 genomic contig, whole genome shotgun sequence
b Primers used only for sequencing
Table 2 Genotype and allele frequency of (GGCGCG)n VNTR in canine NOG gene among seven dog
breeds
Breed (number of animals sampled) Genotype Allele frequency
3 4 5 3/4 3/5 4/5 3 4 5
Miniature Dachshund, long hair (24) 1 7 0 7 7 2 0.333 0.479 0.188
Chihuahua, long hair (25) 3 0 6 5 7 4 0.360 0.180 0.460
Miniature poodle (23) 2 2 2 5 6 6 0.326 0.326 0.348
Shih Tzu (19) 9 0 2 3 4 1 0.658 0.105 0.237
Papillon (13) 5 0 0 2 4 2 0.615 0.154 0.231
Maltese (12) 2 1 0 0 6 3 0.417 0.208 0.375
Yorkshire Terrier (10) 8 0 0 1 1 0 0.900 0.050 0.050
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123using primer sets of CanNOG-F2 and CanNOG-R1 and then puriﬁed with the High
Pure PCR Product Puriﬁcation Kit (Roche Applied Science, Mannheim, Germany).
Puriﬁed DNAs were sequenced directly with the primer CanNOG-F2 as described
above. Heterozygous individuals that had a different number of tandem repeats were
genotyped from their electropherograms.
Results and Discussion
In four domestic dogs, we sequenced the entire coding region of the NOG gene,
which included an unidentiﬁed region of 91 nucleotides in NW_876332. These
nucleotide sequences were entered into the DDBJ, EMBL, and GenBank nucleotide
databases with accession numbers AB544074–AB544077. After multiple alignment
of canine sequences with human NOG (NM_005450) and mouse Nog (NM_008711),
we found that the coding sequence of the canine NOG gene is longer than that of
humans and mice. The coding sequence of the human and mouse genes is
consistently 699 bp in length. The coding sequence in the four dogs showed three
polymorphisms, of 717, 723, and 729 bp, caused by inserted sequences of 18, 24, and
30 bp, respectively. These inserted sequences in the canine NOG gene were
constructed by different numbers of the 6-bp tandem repeats (GGCGCG) unit
(Fig. 1). These GGCGCG tandem repeats immediately preceded the inserted
sequences. Thus, these sequence-length polymorphisms are the result of the
duplicated insertion of this repeat unit. The insertions of tandem repeats were aligned
with the reading frame of the NOG gene and found to encode a Gly–Ala repeat
Fig. 1 The coding region of the canine NOG gene and polymorphisms detected in this study. a Structure
of the coding region of the canine NOG gene. The solid upper line indicates the partial sequence of canine
chromosome 9 (NW_876332), and the broken line represents the undeciphered region in NW_876332.
The start codon of canine NOG was located in the unidentiﬁed region, -91 bp from position 13274612 on
NW_876332. The white blocks of the diagram represent the canine NOG coding sequence, and the shaded
block indicates the region of the inserted sequence. b The nucleotide and amino acid sequences around
the canine-speciﬁc insertion. The repeating units are ruled off by vertical lines. The numbers at the bottom
indicate the number of repetitions. Repetition of GGCGCG was translated into the amino acids Gly–Ala
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present only in mammalian Noggin (Fig. 2). The polyglycine loop is the most
ﬂexible part of the mammalian Noggin protein, as a complex with the BMP ligand
(Groppe et al. 2002). Excluding these inserted-sequence regions, the coding
sequence of the canine NOG gene displayed 96.7% sequence similarity with the
nucleotides of human NOG and 94.0% with mouse Nog. No other polymorphic sites
were found among the four canine NOG sequences, except the above-mentioned
inserted sequences.
We sequenced part of the NOG gene, including the tandem repeat (GGCGCG)n,
in 126 dogs from seven breeds, and identiﬁed three alleles, (GGCGCG)3,
(GGCGCG)4, and (GGCGCG)5, among these individuals (Table 2). The genotypic
and allelic frequencies of these VNTR alleles did not deviate from Hardy–Weinberg
equilibrium among the seven breeds. Although the three alleles of the VNTR were
present in all the dog breeds analyzed in this study, distributions varied widely
among the breeds. (GGCGCG)4 had the highest frequency in the Miniature
Dachshund, whereas (GGCGCG)3 was extremely high in the Shih Tzu, Papillon,
and Yorkshire Terrier (Table 2). Since the three NOG VNTR alleles were
distributed widely among various dog breeds, these sequence-length polymorphisms
arose long before the modern dog breeds were established several hundred years
ago.
Because we collected DNA samples from visibly healthy dogs, each VNTR allele
in the canine NOG gene did not appear to be linked to fatal outcomes and severe
pathological phenotypes in young dogs. Considering the important role of NOG in
bone regeneration and homeostasis in adults (Canalis 2009), however, the three
canine NOG variations theoretically could be associated with susceptibility to bone
or joint disorders in the lifetime of the domestic dog. Nevertheless, the
polymorphisms are most likely silent with respect to function given that (1) the
additional residues encoded by the repeats were inserted in the most ﬂexible portion
of the Noggin protein, (2) the segment is well removed from the ligand-binding
interface, (3) the loop is expanded in other mammals with no apparent loss of
function, and (4) the inserted residues are small and functionally inert in the context
of a disordered loop (Supplementary Fig. 1). In contrast, polymorphisms resulting
in insertion of tracts of polyglutamine in transcription factors can have a toxic
Fig. 2 Comparison of partial amino acid sequences of vertebrate Noggin. Asterisks indicate the
conserved amino acids among the six species. The gray box encloses the polyglycine loop (Gly–Gly–
Gly–Gly–Gly–Ala–Ala) insertion, which is present only in mammalian Noggin (Groppe et al. 2002). The
highlighted letters indicate extension of the Gly–Ala repeat in the canine Noggin. The Gly–Ala repeat is
connected to the polyglycine loop. Citation of sequences: human NM_005450, mouse NM_008711, pig
NM_001143691, dog AF544077, chicken NM_204123, and Xenopus NM_00185644
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changes that disrupt gene regulation (Riley and Orr, 2006) or culminate in formation
of amyloid-like ﬁbrils (Robertson et al. 2011). Indeed, insertion of glutamine repeats
in Runx-2 protein, a transcription factor that regulates osteoblast differentiation, can
have dramatic effects on canine skeletal morphogenesis (Fondon and Garner 2004).
Introduction of amide-containing side-chains, with two functional groups capable of
hydrogen bonding, can enhance interactions within multiprotein transcriptional
complexes, leading to upregulation of target genes involved in skeletogenesis.
Therefore, although polymorphisms within domestic dog breeds can have
pronounced effects on development, the structural context and nature of the side-
chain of the inserted residues appears to dictate whether the effect is functionally
silent, accumulating over evolutionarily large time spans, or pronounced, capable of
generating rapid diversity of form.
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